Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Epha5em1/Cya
Common Name:
Epha5-KO
Product ID:
S-KO-01897
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Epha5-KO
Strain ID
KOCMP-13839-Epha5-B6N-VA
Gene Name
Epha5
Product ID
S-KO-01897
Gene Alias
Cek7; Ehk1; Els1; Hek7; Rek7; bsk
Background
C57BL/6NCya
NCBI ID
13839
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:99654
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Epha5em1/Cya mice (Catalog S-KO-01897) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000053733
NCBI RefSeq
NM_007937
Target Region
Exon 3
Size of Effective Region
~0.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Epha5, a member of the Eph family of tyrosine kinase receptors, plays a role in various biological processes and is associated with multiple signaling pathways such as the Wnt/β -catenin pathway. It has been implicated in carcinogenesis and is important for understanding tumor-related biological functions [3,7,8].

In lung adenocarcinoma, EPHA5 mutations are correlated with enhanced infiltration of CD8+ T cells and M1 macrophages, reduced recruitment of immunosuppressive regulatory T cells, increased levels of chemokine, interferon-gamma, inhibitory immune checkpoint signatures, tumor mutation burden, and tumor neoantigen burden. EPHA5-mutant patients treated with immunotherapy have prolonged survival times [1]. In esophageal squamous cell carcinoma, EphA5 silencing increases radiosensitivity through the ATM-dependent pathway [2]. In non-small cell lung cancer, EPHA5 mutation promotes cell migration and invasion and impairs natural killer cell-mediated cytotoxicity [5]. In HER2-positive breast cancers, deletion of EPHA5 increases trastuzumab resistance by enhancing cancer stem cell-like properties [4]. In gastric cancer, abnormal EPHA5 methylation in peripheral blood leukocytes is related to the cancer risk [6]. In non-small cell lung cancer cells, EPHA5 enhances stemness through activating the Wnt signaling pathway [7]. In esophageal squamous cell carcinoma, EphA5 knockdown promotes proliferation, invasion, and migration via epithelial-mesenchymal transition through activating the Wnt/β-catenin pathway [8].

In conclusion, Epha5 is a key gene involved in cancer-related biological functions. Research on Epha5, especially through gene-knockout or other loss-of-function models, has provided valuable insights into its role in tumor immunity, radiosensitivity, drug resistance, and cell stemness in various cancers, such as lung, esophageal, breast, and gastric cancers. These findings may contribute to the development of new prognostic markers and treatment strategies for these diseases.

References:

1. Chen, Zhiming, Chen, Ji, Ren, Dandan, Mao, Beibei, Ma, Haitao. 2020. EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma. In Aging, 13, 598-618. doi:10.18632/aging.202169. https://pubmed.ncbi.nlm.nih.gov/33288738/

2. Zhang, Rui, Han, Dan, Li, Lu, Liu, Jing, Qian, Liting. 2020. EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway. In Cancer management and research, 12, 9539-9549. doi:10.2147/CMAR.S261182. https://pubmed.ncbi.nlm.nih.gov/33061640/

3. Liu, Chengying, He, Yan, Feng, Xiao, Li, Jie, Wang, Jiandong. 2022. Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation. In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 130, 338-345. doi:10.1111/apm.13222. https://pubmed.ncbi.nlm.nih.gov/35332588/

4. Li, Yongfei, Chu, Jiahui, Feng, Wanting, Huang, Yi, Yin, Yongmei. 2019. EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33, 4851-4865. doi:10.1096/fj.201701561RRRR. https://pubmed.ncbi.nlm.nih.gov/30620624/

5. Zhang, Jingwen, Zhang, Zhihao, Song, Weiwei, Liu, Jumin. 2020. EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion. In Molecular and cellular probes, 52, 101566. doi:10.1016/j.mcp.2020.101566. https://pubmed.ncbi.nlm.nih.gov/32234341/

6. Han, Xu, Liu, Tianyu, Zhai, Jiabao, Zhou, Haibo, Tian, Wenjing. 2022. Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer. In PeerJ, 10, e13774. doi:10.7717/peerj.13774. https://pubmed.ncbi.nlm.nih.gov/36164608/

7. Li, Jie, Zhu, Yehan. . EPHA5 Enhances the Stemness of Non-small cell lung cancer Cells Through Activating the Wnt Signaling Pathway. In Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 26, 1871-1878. doi:. https://pubmed.ncbi.nlm.nih.gov/34761594/

8. Zhang, Rui, Liu, Jing, Zhang, Wei, Qian, Li-Ting, Zhou, Shao-Bing. 2020. EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway. In Cancer cell international, 20, 20. doi:10.1186/s12935-020-1101-x. https://pubmed.ncbi.nlm.nih.gov/31956298/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest